PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
GERM vs. BATT
Performance
Return for Risk
Drawdowns
Volatility
Dividends

GERM vs. BATT

Last updated Jul 17, 2026
Documentation

GERM (Amplify Treatments, Testing and Advancements ETF) and BATT (Amplify Lithium & Battery Technology ETF) are both exchange-traded funds - GERM is a Health & Biotech Equities fund tracking the Prime Treatments, Testing and Advancements Index, while BATT is a Lithium & Battery Metals fund actively managed by Amplify. GERM is passively managed, while BATT is actively managed. Over the past year, GERM returned 0.00% vs 46.82% for BATT. GERM charges 0.68%/yr vs 0.59%/yr for BATT.

Performance

GERM vs. BATT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amplify Treatments, Testing and Advancements ETF (GERM) and Amplify Lithium & Battery Technology ETF (BATT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

GERM

1D
0.00%
1M
0.00%
6M
0.00%
YTD
0.00%
1Y
0.00%
3Y*
—
5Y*
—
10Y*
—

BATT

1D
-3.40%
1M
-15.32%
6M
-6.82%
YTD
2.90%
1Y
46.82%
3Y*
3.71%
5Y*
-1.19%
10Y*
—
*Multi-year figures are annualized to reflect compound growth (CAGR)

GERM vs. BATT - Yearly Performance Comparison

2026 (YTD)20252024
GERM
Amplify Treatments, Testing and Advancements ETF		0.00%0.00%0.00%
BATT
Amplify Lithium & Battery Technology ETF		2.90%59.70%9.18%

GERM vs. BATT - Sectors Allocation Comparison

Sectors
GERM
BATT

Healthcare

99.3%

-

Financial Services

0.4%
0.3%

Basic Materials

-

56.2%

Communication Services

-

0.0%

Consumer Cyclical

-

19.4%

Consumer Defensive

-

-

Energy

-

-

Industrials

-

19.7%

Real Estate

-

-

Technology

-

3.5%

Utilities

-

-

Healthcare

GERM
99.3%
BATT

-

Financial Services

GERM
0.4%
BATT
0.3%

Basic Materials

GERM

-

BATT
56.2%

Communication Services

GERM

-

BATT
0.0%

Consumer Cyclical

GERM

-

BATT
19.4%

Consumer Defensive

GERM

-

BATT

-

Energy

GERM

-

BATT

-

Industrials

GERM

-

BATT
19.7%

Real Estate

GERM

-

BATT

-

Technology

GERM

-

BATT
3.5%

Utilities

GERM

-

BATT

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Amplify Treatments, Testing and Advancements ETF

Amplify Lithium & Battery Technology ETF

Often compared with GERM:
GERM vs. SBIOGERM vs. ARKGGERM vs. GDOCGERM vs. EQRRGERM vs. XBIGERM vs. XLVGERM vs. IHE
Often compared with BATT:
BATT vs. LITBATT vs. LITPBATT vs. IDRVBATT vs. TDVBATT vs. CARSBATT vs. ILITBATT vs. IVW

Return for Risk

GERM vs. BATT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
GERM

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

BATT
BATT Risk / Return Rank: 4949
Overall Rank
BATT Sharpe Ratio Rank: 5050
Sharpe Ratio Rank
BATT Sortino Ratio Rank: 4545
Sortino Ratio Rank
BATT Omega Ratio Rank: 4545
Omega Ratio Rank
BATT Calmar Ratio Rank: 5454
Calmar Ratio Rank
BATT Martin Ratio Rank: 5151
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GERM vs. BATT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amplify Treatments, Testing and Advancements ETF (GERM) and Amplify Lithium & Battery Technology ETF (BATT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

GERMBATTDifference
Sharpe ratioReturn per unit of total volatility

—

1.41

—

Sortino ratioReturn per unit of downside risk

—

1.87

—

Omega ratioGain probability vs. loss probability

—

1.24

—

Calmar ratioReturn relative to maximum drawdown

—

2.21

—

Martin ratioReturn relative to average drawdown

—

6.90

—

GERM vs. BATT - Sharpe Ratio Comparison

Loading charts...

Drawdowns

GERM vs. BATT - Drawdown Comparison

The maximum GERM drawdown since its inception was 0.00%, smaller than the maximum BATT drawdown of -69.38%. Use the drawdown chart below to compare losses from any high point for GERM and BATT.

Loading charts...

Drawdown Indicators

GERMBATTDifference

Max Drawdown

Largest peak-to-trough decline

0.00%

-69.38%

+69.38%

Max Drawdown (1Y)

Largest decline over 1 year

0.00%

-21.24%

+21.24%

Max Drawdown (3Y)

Largest decline over 3 years

—

-47.65%

—

Max Drawdown (5Y)

Largest decline over 5 years

—

-61.98%

—

Current Drawdown

Current decline from peak

0.00%

-21.24%

+21.24%

Average Drawdown

Average peak-to-trough decline

0.00%

-34.47%

+34.47%

Ulcer Index

Depth and duration of drawdowns from previous peaks

0.00%

6.81%

-6.81%

Volatility

GERM vs. BATT - Volatility Comparison

The current volatility for Amplify Treatments, Testing and Advancements ETF (GERM) is 0.00%, while Amplify Lithium & Battery Technology ETF (BATT) has a volatility of 9.38%. This indicates that GERM experiences smaller price fluctuations and is considered to be less risky than BATT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading charts...

Volatility by Period

GERMBATTDifference

Volatility (1M)

Calculated over the trailing 1-month period

0.00%

9.38%

-9.38%

Volatility (6M)

Calculated over the trailing 6-month period

0.00%

27.62%

-27.62%

Volatility (1Y)

Calculated over the trailing 1-year period

0.00%

33.39%

-33.39%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

0.00%

30.06%

-30.06%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

0.00%

30.78%

-30.78%

GERM vs. BATT - Expense Ratio Comparison

GERM has a 0.68% expense ratio, which is higher than BATT's 0.59% expense ratio.

Dividends

GERM vs. BATT - Dividend Comparison

GERM has not paid dividends to shareholders, while BATT's dividend yield for the trailing twelve months is around 1.80%.

PositionTTM20252024202320222021202020192018
BATT
Amplify Lithium & Battery Technology ETF		1.80%1.85%3.17%3.23%4.14%2.32%0.21%3.22%0.89%
GERM
Amplify Treatments, Testing and Advancements ETF		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions

BATT has higher volatility (9.38%) compared to GERM (0.00%). In terms of maximum drawdown, GERM dropped 0.00% vs BATT's -69.38%.

On 1-year performance, BATT leads with 46.82% vs 0.00% for GERM. On fees, BATT is cheaper at 0.59% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, BATT has performed better with a 46.82% return vs 0.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

BATT is cheaper with a 0.59% expense ratio, compared with 0.68% for GERM.

BATT has the higher dividend yield at 1.80%, compared with 0.00% for GERM.

GERM is categorized as Health & Biotech Equities, while BATT is Lithium & Battery Metals. Their fees differ too: 0.68% for GERM and 0.59% for BATT.

Portfolio Optimizer

Find the right allocation for GERM and BATT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer